Search

Your search keyword '"Russo, Roberta"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Russo, Roberta" Remove constraint Author: "Russo, Roberta" Topic humans Remove constraint Topic: humans
53 results on '"Russo, Roberta"'

Search Results

1. The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper

2. Recommendations regarding splenectomy in hereditary hemolytic anemias

3. The European Hematology Association Roadmap for European Hematology Research: a consensus document

4. Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation

5. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores

6. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy

7. Congenital dyserythropoietic anaemias: new acquisitions

8. A first update on mapping the human genetic architecture of COVID-19

9. Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?

10. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism

11. Mapping the human genetic architecture of COVID-19

12. Advances in understanding the pathogenesis of red cell membrane disorders

13. Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition

14. The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant

15. Diagnosis and management of congenital dyserythropoietic anemias

16. Label-Free Optical Marker for Red-Blood-Cell Phenotyping of Inherited Anemias

17. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias

18. Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations

19. Simultaneous abdominal wall defect repair and Tenckhoff catheter placement in candidates for peritoneal dialysis

20. Next generation research and therapy in red blood cell diseases

21. Neuronal hemoglobin affects dopaminergic cells' response to stress

22. Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra highrisk patients

23. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1

24. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II

25. New insights on hereditary erythrocyte membrane defects

26. Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients

27. A Dyserythropoietic Anemia Associated with Homozygous Hb Plasencia [α125(H8)Leu→Arg (α2)] (HBA2:c.377T>G), A Variant with an Unstable α Chain

28. Mutational spectrum in congenital dyserythropoietic anemia type II: Identification of 19 novel variants in SEC23B gene

29. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship

30. A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population

31. Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias

32. Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data

33. Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients?

34. Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II

35. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

36. Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases

37. A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency

38. Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy

39. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population

40. Congenital dyserythropoietic anemias

41. Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives

42. MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness

43. Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d inerythroid cells

44. Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness

45. SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells

46. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II

48. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C

49. Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line

50. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

Catalog

Books, media, physical & digital resources